Stryker Dumps Hip Resurfacing (written by Walter Eisner @ OTW) Stryker Corp. is getting out of the hip resurfacing business. The company said on July 13 that it had cut its distribution and marketing ties with U.K.-based Corin Group PLC, maker of the Cormet hip resurfacing system. Stuart Simpson, Stryker VP of global hip reconstruction marketing, said in a company statement: "Distribution of a hip resurfacing device no longer fits within Stryker's long-term product strategy."
Corin issued a statement saying the company will start a two-month transition to direct distribution. Corin CEO Peter Huntley said: "The integration of Cormet into our extended hip portfolio will put us in a stronger position to service the requirements of the very important US market. Stryker began marketing Corin's Cormet hip in the U.S. shortly after the FDA approved the device in 2007. American patients and surgeons finally had gotten an alternative to Smith & Nephew’s Birmingham hip resurfacing system since the FDA approved that device in May 2006. Stryker had a 10-year distribution agreement with Corin covering sales of the device in the U.S. At the time of the original agre...
Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !

